Trial record 1 of 1 for:    afatinib EAP
Previous Study | Return to List | Next Study

Afatinib Expanded Access Program

Expanded access is currently available for this treatment.
Verified March 2014 by Boehringer Ingelheim
Sponsor:
Information provided by (Responsible Party):
Boehringer Ingelheim
ClinicalTrials.gov Identifier:
NCT01649284
First received: July 23, 2012
Last updated: March 5, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: Expanded access is currently available for this treatment.
  Study Completion Date: December 2013
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)